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ABSTRACT
Objective: To identify some of the virulence factors such as hemolysin, gelatinase, and biofilm production among the clinical isolates of enterococci.
Methods: Hemolysin detection using sheep blood agar. Gelatine agar was used for gelatinase production, and tube adherence method was used for 
detecting biofilm production.
Results: Hemolysin production observed in 49% of isolates, gelatinase production in 41% of isolates, and 46% of isolates were produced biofilm.
Conclusion: Virulence factors production was noticed more in Enterococcus faecalis than Enterococcus faecium. It is necessary to find the 
production of important virulence factors among the clinical isolates as they are always associated with virulence of the organism including drug 
resistance.
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INTRODUCTION
Enterococci are Gram-positive, facultative anaerobic bacteria 
classified as Group D streptococci. They have developed well-adapted 
mechanism to survive in the gastrointestinal tract of the human 
being as a commensal, but these opportunistic bacteria sometimes 
become pathogen and cause dangerous infections such as bacteremia, 
endocarditis, urinary tract infections, intra-abdominal and pelvic 
infection, surgical site infection, and diabetic foot infection [1].
Among the Enterococcal isolates, Enterococcus faecalis and Enterococcus 
faecium are the leading cause of nosocomial infections (E. faecalis 
85-90% and E. faecium 5-10%). Several potential virulence factors have 
been identified in enterococci, but none has been established as having 
a major contribution to virulence in human [2].
Hemolysin also called as cytolysin and is a post-translationally 
modified protein toxin that occurs in many strains of enterococci [3]. In 
E. faecalis, it can occur up to 60%. Cytolysin causes rupture of different 
target membranes, including erythrocytes, bacterial cells, and other 
mammalian cells [4]. Hemolysin played a role in human infections 
was proved in Japan; about 60% clinical isolates from Enterococcal 
infections were hemolytic compared with only 17% of isolates from 
feces of healthy individuals [5]. Gelatinase (Gel E) is an extracellular 
protease which is produced by enterococci and is consider as one of the 
important virulent factors. It is capable of hydrolyzing gelatine, casein, 
collagen, hemoglobin, and other peptides [4]. Gelatinase of E. faecalis 
gene is cotranscribed with sprE gene encoding serine protease. These 
two proteases give nutrition to bacteria and directly or indirectly cause 
damage to host tissues [6]. Proteolytic activity of gelatinase contributes 
an important role in the pathogenicity of E. faecalis [7].
Enterococci has an ability to produce biofilm on abiotic surfaces is 
said to be another important virulence factor [8]. The enterococci 
have been associated with biofilm in endocarditis, root canal infection, 
and ocular infection and urinary tract infection and in a variety of 
device-related infection in which biofilm was found on intrauterine 
devices, prosthetic heart valves, artificial hip prostheses catheters, 
and stents [9]. Biofilm production is nosocomial strains of organisms 
is an important pathogenic factor in causing infection in the hospital 
environment [10].
Our study was aimed to identify different species of enterococci isolated 
from the clinical samples and also to identify some of the virulence 
factors such as hemolysin, gelatinase, and biofilm production among 
the clinical isolates of enterococci.
METHODS
Clinical isolates of Enterococcus were identified phenotypically by 
standard biochemical tests up to species level.
Species identification
Species identification was done by motility testing, pigment production, 
and fermentation from various sugars and pyruvate [2,11].
Motility
Motility was observed by Hanging drop preparations. All enterococci 
are non-motile except Enterococcus gallinarum, Enterococcus 
casseliflavus, and Enterococcus flavascens, which are not common 
human pathogens.
Pigment production
Pigment production is easily detected in nutrient agar plates. 
Inoculate the organism in the nutrient agar plate and incubate at 37°C 
for overnight and observed for any pigment production. Common 
pathogenic enterococci are not producing pigment. Some enterococci 
are pigment producing such as Enterococcus mundtii, E. casseliflavus, E. 
flavascens, and Enterococcus sulfureus.
Sugar fermentation
Mannitol fermentation, arabinose fermentation, raffinose fermentation, 
and pyruvate fermentation were done to speciate Enterococcus
Detection of virulence factors
Hemolysin (cytolysin) production
Hemolysin production was detected by inoculating enterococci onto 
freshly prepared blood agar plates. Plates were incubated at 37°C and 
evaluated after 24 and 48 hrs. A clear zone of β-hemolysis around the 
stab or streak on human blood agar was considered to be a positive 
indication of hemolysin production [2,12].
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Production (Fig. 1)
Gelatine agar is prepared by adding gelatine to nutrient medium. The 
organism is inoculated in gelatine agar plate and incubated at 37°C for 
24 hrs. Then, the plate is flooded with mercuric chloride and clear zone 
around the colonies indicate gelatinase production [2,12].
Biofilm production
Tube adherence method (Fig. 2)
Trypticase soy broth 10 ml was taken in sterile test tubes and was 
inoculated with loopful of micro-organism from overnight culture 
plates and incubated for 24 hrs at 37°C. The tubes were decanted and 
washed with phosphate buffer solution (PH 7.3) and dried. The dried 
test tubes were stained with crystal violet (0.1%). Excess stain was 
removed, and tubes were washed with deionized water. Tubes were 
then dried in inverted position and observed for biofilm formation. The 
biofilm formation was positive when a visible film lined the wall and 
bottom of the tube.
Ring formation at the liquid interface was not indicative of biofilm 
formation. Tubes were examined, and amount of biofilm formation was 
scored as 0-absent, 1-week, 2-moderate, and 3-strong [2,12].
RESULTS
Out of 100 isolates of Enterococcal spp. from various clinical specimen 
received from our hospital, we identified 89 (89%) E. faecalis and 
11 (11%) E. faecium.
Out of 89 isolates of E. faecalis identified, 72 (83%) from urine samples, 
14 (15.7%) from pus samples, and 3 (3.3%) from blood samples. Out of 
11 isolates of E. faecium identified, 8 (72.7%) from urine samples and 
3 (27.2%) from pus samples (Table 1).
All isolates were detected for virulence factors production. Common 
virulence factors in Enterococcal spp. are hemolysin, gelatinase, 
and biofilm. Among 89 E. faecalis, 46 (51.68%) were producing 
hemolysin, 39 (43.8%) were producing gelatinase, and 42 (47.19%) 
were producing biofilm. Out of 11 E. faecium, 3 (27.27%) producing 
hemolysin, 2 (18.18%) were producing gelatinase, and 4 (36.36%) were 
producing biofilm. A total of 49 (49%) hemolysin, 41 (41%) gelatinase 
and 46 (46%) biofilm were produced (Table 2).
Some of the isolates showed production of more than one virulent 
factors. 22 (21%) isolates were identified as multiple virulent factors 
producers. 11 (11%) isolates were producing all three virulent factors 
included in our study. 10 (10%) isolates were produced two virulent 
factors. Of which, 6 of them produced both biofilm and hemolysin, 3 
isolates were produced both biofilm and gelatinase, and only 1 showed 
the production of hemolysin and gelatinase.
DISCUSSION
Enterococci once considered a harmless commensal survive in the 
gastrointestinal tract of human has emerged as a medically important 
multidrug-resistant virulent pathogen causing outbreaks of many 
dangerous nosocomial infections such as bacteremia, endocarditis, 
urinary tract infections, intra-abdominal and pelvic infection, surgical 
site infection, and diabetic foot infection [1].
In our study, 100 strains of Enterococcal spp. were isolated from 
various clinical samples during a period of 1-year. Among 100 isolates, 
89 (89%) were identified as E. faecalis, and 11 (11%) were identified as 
E. faecium. In 2008, a study by Jayanthi et al. reported that 80-90% of 
all Enterococcal infections were caused by E. faecalis [13]. A study from 
London, Teixeira et al. reported that E. faecalis and E. faecium are the 
leading cause of nosocomial infection (E. faecalis 85-90% and E. faecium 
5-10%) [2]. In the year 2005, a study by Coque et al. showed isolation 
of 77% E. faecalis and 15% E. faecium from blood [14]. E. faecalis is 
still being the most common species among Enterococcus isolated from 
clinical specimens.
All isolates were tested for virulence factors production. The presence of 
virulence factors indicates the severity of pathogenicity in any bacteria. 
Common virulence factors in Enterococcal spp. such as hemolysin, 
gelatinase, and biofilm were studied. In our study, 46 (51.68%) 
E. faecalis strains and 3 (27.27%) E. faecium were produced hemolysin. 
Hemolysin also called as cytolysin and is a modified protein toxin that 
occurs in many strains of enterococci [15]. A study from Bangalore 
showed that 16.5% clinical and 19% commensal isolates produce 
hemolysin which is less when compared to our study. Another study 
from Turkey by Gulhan et al. reported that hemolysin production 
was detected in 50% of E. faecalis isolates and 18.2% in E. faecium 
Fig. 1: Gelatinase production
Fig. 2: Tube adherence test for biofilm production







Urine (%) 72 (83) 8 (72.7) 80 (80)
Pus (%) 14 (15.7) 3 (27.2) 17 (17)
Blood (%) 3 (3.3) 0 (0) 3 (3)
E. faecalis: Enterococcus faecalis, E. faecium: Enterococcus faecium









Hemolysin (%) 46 (51.68) 3 (27.27) 49 (49)
Gelatinase (%) 39 (43.8) 2 (18.18) 41 (41)
Biofilm (%) 42 (47.19) 4 (36.36) 46 (46)
E. faecalis: Enterococcus faecalis, E. faecium: Enterococcus faecium
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isolates [16]. In 2012, a study conducted by Dahlen et al. reported 
that hemolysin was detected in 16.7% of the E. faecalis strains, and 
none of the E. faecium isolates produces hemolysin [15]. In the year 
2008, Jankoska et al. reported that occurrence of hemolysin up to 60% 
of clinical isolates and also reported that 50% of E. faecalis produced 
hemolysin [4]. In our study, we found that hemolysin was mainly 
produced by E. faecalis species than E. faecium which was reported 
by most of the other studies also. Most of the studies reported less 
rate of hemolysin production by both the isolates. Hemolysin played 
a role in human infections was proved in Japan; about 60% clinical 
isolates from Enterococcal infections were hemolytic compared with 
only 17% of isolates from feces of healthy individuals [5]. However, in 
our study, as we have not compared clinical isolates with commensals 
from healthy individuals, that cannot be proved which is one of the 
drawbacks of our study.
Gelatinase is an extracellular protease and is considered as one of 
the important virulent factors produced by enterococci. Gelatinase 
has a proteolytic activity which contributes an important role in 
the pathogenicity of E. faecalis [6]. In our study, 39 (43.8%) isolates 
of E. faecalis and 2 (18.18%) isolates of E. faecium were producing 
gelatinase. A study from India by Upadhyaya et al., in the year 2009, 
reported that 39% clinical isolates were producing gelatinase [10]. 
Another study by Strzelecki et al. from Poland reported that, of 153 
E. faecalis, 53% of strains producing gelatinase, and among these, 
isolates from CSF were commonly producing gelatinase (75%) 
followed by isolates from urine (71%) less frequently by isolates from 
wound and blood. In the year 2000, a study by Qin et al. reported that 
62% of E. faecalis produced gelatinase and the presence of gelatinase 
contributes to the virulence of E. faecalis [17]. In the year 2008, 
Jankoska et al. reported that the occurrence of gelatinase production 
was identified in 68% of E. faecalis of urine sample [4]. A study by 
Gulhan et al. found gelatinase production was common in both 
E. faecalis and E. faecium [16]. In our study, we found that gelatinase 
was largely produced by E. faecalis than E. faecium, and this was 
proved by most of the other studies.
Enterococci has an ability to produce biofilm on abiotic surfaces is 
said to be an important virulence factor [18]. Biofilm is an assembly 
of microbial cells associated with a surface and enclosed in a matrix of 
primarily polysaccharide material. The biofilm producing enterococci 
have been associated with endocarditis, root canal infection, and 
ocular infection and urinary tract infections and in a variety of 
device-related infections such as intrauterine devices, prosthetic 
heart valves, artificial hip prostheses catheters, and stents [8]. In our 
study, 42 (47.19%) isolates of E. faecalis and 4 (36.36%) isolates of E. 
faecium were producing biofilm, respectively. Upadhyaya et al. from 
India reported that 32% of clinical isolates were producing biofilm, 
but only 16% of commensal isolates were producing biofilm [10]. The 
worldwide biofilm producing prevalence was varied from each other 
country. In the United States, a study by Mohamed et al. reported that 
93% of E. faecalis identified as biofilm producing isolates [19]. In the 
year 2008, Jankoska et al. reported that the occurrence of biofilm was 
found in 76% of E. faecalis from the urine isolates [4]. The production of 
biofilm is greater in gelatinase producing isolates than non-gelatinase 
producing isolates [17].
Two or more virulence factors present in some strains of E. faecalis, 
whereas 72.1% of E. faecalis were present with any one of the virulence 
factors most frequently biofilm production [20]. In our study also, 
there were isolates which produced multiple virulent factors. A total 
of 21% of isolates have shown production of all three virulent factors 
which we have studied. There was no clinical significance proved 
due to their multiple virulent factor production. Most of the foreign 
studies showed that more than 75% of E. faecalis produced Biofilm, 
but in our study, we found only 47% of E. faecalis were producing 
biofilm. Another Indian study showed that the low prevalence of 
biofilm production. Our study correlates with the Indian study proved 
that biofilm production was low in India. Biofilm production has got 
more significance especially if the isolate is from any medical device. 
A study from Iran in 2015 proved an association of biofilm production 
with drug resistance [21]. This has to be taken into consideration for 
selecting empirical antibiotic before culture report. Because near 
about 50% of isolates in our study showed biofilm production which 
reflects drug resistance percentage also.
CONCLUSION
The prevalence of Virulence factors, which we have been studied, 
is high in E. faecalis than E. faecium. As these virulence factors’ 
production is associated with drug resistance in that particular 
isolate, these type of studies will give an idea about the prevalence 
of such virulence factors which will help in the treatment of the 
patients infected with Enterococcus species. Our limitation in this 
study is that we have not compared pathogenic strains isolated 
from the clinical specimen with the commensals from healthy 
individuals.
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